DH
Definitive Healthcare Corp. [DH] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
DH Stock Summary
Top 10 Correlated ETFs
DH
Top 10 Correlated Stocks
DH
In the News
DH Financial details
Company Rating
Neutral
Market Cap
865.75M
Income
-205.93M
Revenue
251.42M
Book val./share
7.4
Cash/share
2.65
Dividend
-
Dividend %
-
Employees
950
Optionable
No
Shortable
Yes
Earnings
02 May 2024
P/E
-5.67
Forward P/E
-
PEG
-0.08
P/S
4.42
P/B
1.24
P/C
2.66
P/FCF
43.54
Quick Ratio
2.37
Current Ratio
2.55
Debt / Equity
0.3
LT Debt / Equity
0.2
-
-
EPS (TTM)
-1.8
EPS next Y
-
EPS next Q
-
EPS this Y
713.64%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
49.46%
Revenue last 5Y
24.07%
Revenue Q/Q
0.93%
EPS Q/Q
-94.14%
-
-
-
-
SMA20
-12.5%
SMA50
-22.22%
SMA100
-12.5%
Inst Own
38.23%
Inst Trans
0.36%
ROA
-10%
ROE
-20%
ROC
-0.2%
Gross Margin
82%
Oper. Margin
-133%
Profit Margin
-77%
Payout
-9%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
5.53-12.455
52W High
-41.33%
52W Low
+40.8%
RSI
34
Rel Volume
0.51
Avg Volume
528.52K
Volume
272.06K
Perf Week
-8.93%
Perf Month
-15.99%
Perf Quarter
15.22%
Perf Half Y
3.53%
-
-
-
-
Beta
1.392
-
-
Volatility
0.2%, 0.36%
Prev Close
-2.09%
Price
7.04
Change
-3.43%
DH Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.57 | 1.22 | 1.71 | 2.2 | 2.23 | |
| Net income per share | -0.24 | -0.9 | -0.63 | -0.22 | -1.79 | |
| Operating cash flow per share | 0.14 | 0.24 | 0.26 | 0.35 | 0.37 | |
| Free cash flow per share | 0.13 | 0.22 | 0.19 | 0.27 | 0.34 | |
| Cash per share | 0.06 | 0.26 | 3.99 | 3.28 | 2.73 | |
| Book value per share | 8.16 | 12.32 | 9 | 9.42 | 7.64 | |
| Tangible book value per share | -3.11 | -4.91 | -1.14 | -1.85 | -1.76 | |
| Share holders equity per share | 8.16 | 12.32 | 9 | 9.42 | 7.64 | |
| Interest debt per share | 3.07 | 5.14 | 3.06 | 2.81 | 2.43 | |
| Market cap | 6.45B | 4.2B | 2.65B | 1.11B | 1.12B | |
| Enterprise value | 6.89B | 4.64B | 2.54B | 1.24B | 1.26B | |
| P/E ratio | -177.33 | -47.92 | -43.29 | -49.93 | -5.54 | |
| Price to sales ratio | 75.49 | 35.5 | 15.96 | 4.99 | 4.46 | |
| POCF ratio | 298.9 | 180.92 | 105.18 | 31.23 | 27.21 | |
| PFCF ratio | 327.74 | 192.49 | 143.49 | 40.78 | 29.33 | |
| P/B Ratio | 5.31 | 3.51 | 3.04 | 1.17 | 1.3 | |
| PTB ratio | 5.31 | 3.51 | 3.04 | 1.17 | 1.3 | |
| EV to sales | 80.53 | 39.2 | 15.26 | 5.57 | 5 | |
| Enterprise value over EBITDA | 219.54 | 94.81 | 61.45 | 36.73 | 60.36 | |
| EV to operating cash flow | 318.85 | 199.75 | 100.55 | 34.86 | 30.54 | |
| EV to free cash flow | 349.61 | 212.52 | 137.17 | 45.51 | 32.92 | |
| Earnings yield | -0.01 | -0.02 | -0.02 | -0.02 | -0.18 | |
| Free cash flow yield | 0 | 0.01 | 0.01 | 0.02 | 0.03 | |
| Debt to equity | 0.36 | 0.39 | 0.31 | 0.29 | 0.3 | |
| Debt to assets | 0.26 | 0.26 | 0.13 | 0.13 | 0.14 | |
| Net debt to EBITDA | 13.73 | 8.94 | -2.83 | 3.82 | 6.57 | |
| Current ratio | 0.52 | 0.72 | 3.83 | 3.12 | 2.23 | |
| Interest coverage | -0.12 | -0.29 | -0.72 | -2.75 | -2.03 | |
| Income quality | -0.59 | -0.45 | -0.41 | -1.6 | -0.2 | |
| Dividend Yield | 0 | 0 | 0 | 0.01 | 0.01 | |
| Payout ratio | -0.19 | -0.03 | -0.13 | -0.58 | -0.06 | |
| Sales general and administrative to revenue | 0.12 | 0.11 | 0.18 | 0.22 | 0.23 | |
| Research and developement to revenue | 0.09 | 0.09 | 0.11 | 0.16 | 0.17 | |
| Intangibles to total assets | 0.98 | 0.96 | 0.76 | 0.79 | 0.77 | |
| Capex to operating cash flow | -0.09 | -0.06 | -0.27 | -0.23 | -0.07 | |
| Capex to revenue | -0.02 | -0.01 | -0.04 | -0.04 | -0.01 | |
| Capex to depreciation | -0.06 | -0.02 | -0.11 | -0.15 | -0.06 | |
| Stock based compensation to revenue | 0.08 | 0.01 | 0.06 | 0.16 | 0.19 | |
| Graham number | 6.69 | 15.82 | 11.31 | 6.83 | 17.56 | |
| ROIC | 0 | -0.01 | -0.02 | -0.01 | -0.03 | |
| Return on tangible assets | -0.87 | -1.19 | -0.12 | -0.05 | -0.47 | |
| Graham Net | -3.2 | -5.16 | -1.95 | -2.5 | -2.43 | |
| Working capital | -33.81M | -24.88M | 333.76M | 281.24M | 209.76M | |
| Tangible asset value | -463.31M | -476.12M | -110.65M | -186.6M | -199.03M | |
| Net current asset value | -468.81M | -485.95M | -161.17M | -220.03M | -246.29M | |
| Invested capital | 0.36 | 0.39 | 0.31 | 0.29 | 0.3 | |
| Average receivables | 0 | 29.06M | 38.22M | 51.07M | 59.02M | |
| Average payables | 0 | 3.91M | 5.16M | 4.3M | 4.87M | |
| Average inventory | 0 | 1 | 3.66M | 8.86M | 5.19M | |
| Days sales outstanding | 106.81 | 102.14 | 95.2 | 96.39 | 86.02 | |
| Days payables outstanding | 18.29 | 67.83 | 41.72 | 33.81 | 24.42 | |
| Days of inventory on hand | 0 | 0 | 65.71 | 88.94 | 0 | |
| Receivables turnover | 3.42 | 3.57 | 3.83 | 3.79 | 4.24 | |
| Payables turnover | 19.95 | 5.38 | 8.75 | 10.8 | 14.95 | |
| Inventory turnover | 43.04M | 30.47M | 5.55 | 4.1 | 0 | |
| ROE | -0.03 | -0.07 | -0.07 | -0.02 | -0.23 | |
| Capex per share | -0.01 | -0.01 | -0.07 | -0.08 | -0.03 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.58 | 0.55 | 0.55 | 0.57 | 0.57 | |
| Net income per share | 0.06 | -0.14 | -0.08 | -1.5 | -0.09 | |
| Operating cash flow per share | -0.04 | 0.14 | 0.11 | 0.08 | 0.04 | |
| Free cash flow per share | -0.09 | 0.13 | 0.1 | 0.08 | 0.04 | |
| Cash per share | 3.16 | 3.18 | 3.14 | 2.68 | 2.65 | |
| Book value per share | 9.06 | 9.13 | 9.02 | 7.54 | 7.4 | |
| Tangible book value per share | -1.78 | -1.77 | -1.75 | -1.8 | -1.71 | |
| Share holders equity per share | 9.06 | 9.13 | 9.02 | 7.54 | 7.4 | |
| Interest debt per share | 2.64 | 2.54 | 2.47 | 2.38 | 2.25 | |
| Market cap | 1.15B | 1.12B | 1.23B | 915.07M | 1.16B | |
| Enterprise value | 1.28B | 1.27B | 1.37B | 1.11B | 1.29B | |
| P/E ratio | 42.87 | -17.92 | -35.88 | -1.33 | -28.27 | |
| Price to sales ratio | 19.06 | 18.89 | 20.17 | 14.01 | 17.55 | |
| POCF ratio | -273.66 | 74.75 | 102.14 | 96.46 | 245.74 | |
| PFCF ratio | -127.03 | 82.1 | 108.83 | 99.66 | 281.22 | |
| P/B Ratio | 1.21 | 1.13 | 1.22 | 1.06 | 1.34 | |
| PTB ratio | 1.21 | 1.13 | 1.22 | 1.06 | 1.34 | |
| EV to sales | 21.18 | 21.4 | 22.46 | 16.98 | 19.63 | |
| Enterprise value over EBITDA | 238.27 | 316.75K | 194.1 | 29.08 | 272.8 | |
| EV to operating cash flow | -304.21 | 84.71 | 113.73 | 116.92 | 274.83 | |
| EV to free cash flow | -141.21 | 93.03 | 121.18 | 120.8 | 314.5 | |
| Earnings yield | 0.01 | -0.01 | -0.01 | -0.19 | -0.01 | |
| Free cash flow yield | -0.01 | 0.01 | 0.01 | 0.01 | 0 | |
| Debt to equity | 0.29 | 0.28 | 0.27 | 0.31 | 0.3 | |
| Debt to assets | 0.13 | 0.13 | 0.13 | 0.15 | 0.14 | |
| Net debt to EBITDA | 23.93 | 37.24K | 19.78 | 5.09 | 28.87 | |
| Current ratio | 3.12 | 2.96 | 2.84 | 2.55 | 2.23 | |
| Interest coverage | -4.92 | -16.59 | -3.18 | -682.17 | -2.12 | |
| Income quality | -0.63 | -0.96 | -1.01 | -0.04 | -0.46 | |
| Dividend Yield | 0.01 | 0 | 0 | 0.01 | 0 | |
| Payout ratio | 0.88 | -0.1 | -0.33 | -0.05 | -0.16 | |
| Sales general and administrative to revenue | 0.25 | 0.23 | 0.22 | 0.22 | 0.25 | |
| Research and developement to revenue | 0.17 | 0.17 | 0.17 | 0.16 | 0.18 | |
| Intangibles to total assets | 0.79 | 0.79 | 0.78 | 0.77 | 0.77 | |
| Capex to operating cash flow | 1.15 | -0.09 | -0.06 | -0.03 | -0.13 | |
| Capex to revenue | -0.08 | -0.02 | -0.01 | 0 | -0.01 | |
| Capex to depreciation | -0.38 | -0.1 | -0.06 | -0.02 | -0.05 | |
| Stock based compensation to revenue | 0.19 | 0.19 | 0.2 | 0.18 | 0.2 | |
| Graham number | 3.61 | 5.44 | 3.94 | 15.94 | 3.83 | |
| ROIC | 0 | -0.01 | -0.01 | -0.24 | -0.01 | |
| Return on tangible assets | 0.02 | -0.03 | -0.02 | -0.42 | -0.02 | |
| Graham Net | -2.4 | -2.38 | -2.32 | -2.37 | -2.36 | |
| Working capital | 281.24M | 278.87M | 272.92M | 228.25M | 209.76M | |
| Tangible asset value | -186.6M | -191.95M | -195.07M | -206.56M | -199.03M | |
| Net current asset value | -220.03M | -224.29M | -228.36M | -240.69M | -246.29M | |
| Invested capital | 0.29 | 0.28 | 0.27 | 0.31 | 0.3 | |
| Average receivables | 46.24M | 55.3M | 48.16M | 42.91M | 50.28M | |
| Average payables | 7.11M | 4.24M | 4.09M | 4.61M | 5.68M | |
| Average inventory | 3.68M | 10.73M | 11.48M | 12.14M | 6.2M | |
| Days sales outstanding | 87.33 | 78.75 | 65.73 | 56.91 | 80.88 | |
| Days payables outstanding | 36.28 | 34.28 | 29.41 | 42.12 | 23.2 | |
| Days of inventory on hand | 95.44 | 83.64 | 95.81 | 93.79 | 0 | |
| Receivables turnover | 1.03 | 1.14 | 1.37 | 1.58 | 1.11 | |
| Payables turnover | 2.48 | 2.63 | 3.06 | 2.14 | 3.88 | |
| Inventory turnover | 0.94 | 1.08 | 0.94 | 0.96 | 0 | |
| ROE | 0.01 | -0.02 | -0.01 | -0.2 | -0.01 | |
| Capex per share | -0.05 | -0.01 | -0.01 | 0 | -0.01 |
DH Frequently Asked Questions
What is Definitive Healthcare Corp. stock symbol ?
Definitive Healthcare Corp. is a US stock , located in Framingham of Ma and trading under the symbol DH
What is Definitive Healthcare Corp. stock quote today ?
Definitive Healthcare Corp. stock price is $7.04 today.
Is Definitive Healthcare Corp. stock public?
Yes, Definitive Healthcare Corp. is a publicly traded company.
Company Profile
- Volume Average 528.52K
- Market Capitalization 865.75M
- Employee 950
- CEO Mr. Jason Ronald Krantz
- Headquarters Framingham,MA,US
- IPO Date 2021-09-15
-
Website
https://www.definitivehc.com 
Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
